Chemoinformaics analysis of Cyclohexane, 1-methylene-4-(1-methylethylidene)-
Molecular Weight | 136.238 | nRot | 0 |
Heavy Atom Molecular Weight | 120.11 | nRig | 8 |
Exact Molecular Weight | 136.125 | nRing | 1 |
Solubility: LogS | -3.272 | nHRing | 0 |
Solubility: LogP | 3.487 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
Atoms Count | 26 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 10 | No. of Aromatic Carbocycles | 0 |
nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 1 |
No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 10 | No. of Saturated Rings | 1 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
nHA | 0 | APOL | 27.3687 |
nHD | 0 | BPOL | 16.0513 |
QED | 0.447 |
Synth | 3.251 |
Natural Product Likeliness | 1.822 |
NR-PPAR-gamma | 0.007 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0.21 |
Pgp-sub | 0 |
HIA | 0.002 |
CACO-2 | -4.52 |
MDCK | 0.0000154 |
BBB | 0.985 |
PPB | 0.916353 |
VDSS | 3.642 |
FU | 0.0385916 |
CYP1A2-inh | 0.74 |
CYP1A2-sub | 0.558 |
CYP2c19-inh | 0.138 |
CYP2c19-sub | 0.594 |
CYP2c9-inh | 0.109 |
CYP2c9-sub | 0.876 |
CYP2d6-inh | 0.015 |
CYP2d6-sub | 0.676 |
CYP3a4-inh | 0.024 |
CYP3a4-sub | 0.214 |
CL | 11.286 |
T12 | 0.365 |
hERG | 0.02 |
Ames | 0.007 |
ROA | 0.008 |
SkinSen | 0.098 |
Carcinogencity | 0.841 |
EI | 0.972 |
Respiratory | 0.032 |
NR-Aromatase | 0.009 |
Antiviral | No |
Prediction | 0.938956 |